首页> 外文OA文献 >Expression-Based Network Biology Identifies Alteration in Key Regulatory Pathways of Type 2 Diabetes and Associated Risk/Complications
【2h】

Expression-Based Network Biology Identifies Alteration in Key Regulatory Pathways of Type 2 Diabetes and Associated Risk/Complications

机译:基于表达的网络生物学识别2型糖尿病和相关风险/并发症的关键调控途径的改变。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Type 2 diabetes mellitus (T2D) is a multifactorial and genetically heterogeneous disease which leads to impaired glucose homeostasis and insulin resistance. The advanced form of disease causes acute cardiovascular, renal, neurological and microvascular complications. Thus there is a constant need to discover new and efficient treatment against the disease by seeking to uncover various novel alternate signalling mechanisms that can lead to diabetes and its associated complications. The present study allows detection of molecular targets by unravelling their role in altered biological pathways during diabetes and its associated risk factors and complications. We have used an integrated functional networks concept by merging co-expression network and interaction network to detect the transcriptionally altered pathways and regulations involved in the disease. Our analysis reports four novel significant networks which could lead to the development of diabetes and other associated dysfunctions. (a) The first network illustrates the up regulation of TGFBRII facilitating oxidative stress and causing the expression of early transcription genes via MAPK pathway leading to cardiovascular and kidney related complications. (b) The second network demonstrates novel interactions between GAPDH and inflammatory and proliferation candidate genes i.e., SUMO4 and EGFR indicating a new link between obesity and diabetes. (c) The third network portrays unique interactions PTPN1 with EGFR and CAV1 which could lead to an impaired vascular function in diabetic nephropathy condition. (d) Lastly, from our fourth network we have inferred that the interaction of β-catenin with CDH5 and TGFBR1 through Smad molecules could contribute to endothelial dysfunction. A probability of emergence of kidney complication might be suggested in T2D condition. An experimental investigation on this aspect may further provide more decisive observation in drug target identification and better understanding of the pathophysiology of T2D and its complications.
机译:2型糖尿病(T2D)是一种多因素遗传遗传疾病,可导致葡萄糖稳态和胰岛素抵抗受损。疾病的晚期形式引起急性心血管,肾,神经和微血管并发症。因此,始终需要通过寻求发现可能导致糖尿病及其相关并发症的各种新颖的替代信号传导机制来发现针对该疾病的新的有效治疗方法。本研究允许通过揭示分子靶标在糖尿病期间改变的生物途径中的作用及其相关的危险因素和并发症来检测分子靶标。我们通过合并共表达网络和相互作用网络使用了集成的功能网络概念来检测与疾病有关的转录改变的途径和调控。我们的分析报告了四个新的重要网络,这些网络可能导致糖尿病和其他相关功能障碍的发展。 (a)第一个网络说明了TGFBRII的上调,从而促进氧化应激并通过MAPK途径引起早期转录基因的表达,从而导致心血管和肾脏相关并发症。 (b)第二个网络证明了GAPDH与炎症和增殖候选基因即SUMO4和EGFR之间的新型相互作用,表明肥胖症和糖尿病之间存在新的联系。 (c)第三个网络描绘了PTPN1与EGFR和CAV1的独特相互作用,这可能导致糖尿病性肾病患者血管功能受损。 (d)最后,从我们的第四个网络中我们推断出,β-catenin通过Smad分子与CDH5和TGFBR1的相互作用可能导致内皮功能障碍。在T2D情况下,可能提示出现肾脏并发症的可能性。在这方面的实验研究可能会在确定药物靶标和更好地了解T2D的病理生理及其并发症方面提供更多的决定性观察。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号